93 related articles for article (PubMed ID: 30227269)
1. A novel S-nitrosocaptopril monohydrate for pulmonary arterial hypertension: H
Zhou Y; Lin M; Wang J; Chen F; Li F; Chen W; Han L; Wang C; Chen J; Shao JW; Jia L
Free Radic Biol Med; 2018 Dec; 129():107-115. PubMed ID: 30227269
[TBL] [Abstract][Full Text] [Related]
2. Physicochemistry, pharmacokinetics, and pharmacodynamics of S-nitrosocaptopril crystals, a new nitric oxide donor.
Jia L; Young X; Guo W
J Pharm Sci; 1999 Oct; 88(10):981-6. PubMed ID: 10514343
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effects of S-nitrosocaptopril on vasomotor tone.
Lin MJ; Yang XP; Wang J; Jia BJ; Jia L
Zhongguo Yao Li Xue Bao; 1998 Sep; 19(5):485-8. PubMed ID: 10375817
[TBL] [Abstract][Full Text] [Related]
4. Acute and subacute toxicity and efficacy of S-nitrosylated captopril, an ACE inhibitor possessing nitric oxide activities.
Jia L; Pei R; Lin M; Yang X
Food Chem Toxicol; 2001 Dec; 39(12):1135-43. PubMed ID: 11696388
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo assessment of cellular permeability and pharmacodynamics of S-nitrosylated captopril, a nitric oxide donor.
Jia L; Wong H
Br J Pharmacol; 2001 Dec; 134(8):1697-704. PubMed ID: 11739246
[TBL] [Abstract][Full Text] [Related]
6. Optimization of S-Nitrosocaptopril Monohydrate Storage Conditions Based on Response Surface Method.
Huang L; Zhou Y; Wang Y; Lin M
Molecules; 2021 Dec; 26(24):. PubMed ID: 34946614
[TBL] [Abstract][Full Text] [Related]
7. The effects of S-nitrosocaptopril on renal filtration and blood pressure in rats.
Jia L; Blantz RC
Eur J Pharmacol; 1998 Jul; 354(1):33-41. PubMed ID: 9726628
[TBL] [Abstract][Full Text] [Related]
8. Antiangiogenic effects of S-nitrosocaptopril crystals as a nitric oxide donor.
Jia L; Wu CC; Guo W; Young X
Eur J Pharmacol; 2000 Mar; 391(1-2):137-44. PubMed ID: 10720645
[TBL] [Abstract][Full Text] [Related]
9. S-Nitrosocaptopril prevents cancer metastasis in vivo by creating the hostile bloodstream microenvironment against circulating tumor cells.
Lu Y; Lian S; Ye Y; Yu T; Liang H; Cheng Y; Xie J; Zhu Y; Xie X; Yu S; Gao Y; Jia L
Pharmacol Res; 2019 Jan; 139():535-549. PubMed ID: 30366102
[TBL] [Abstract][Full Text] [Related]
10. [A design of a novel compound S-nitrosocaptopril possessing the capacities of both angiotensin converting enzyme inhibitors and NO donors].
Jia L
Sheng Li Ke Xue Jin Zhan; 1999 Jan; 30(1):53-6. PubMed ID: 12532851
[No Abstract] [Full Text] [Related]
11. ACE inhibition restores the vasodilator potency of the endothelium-derived relaxing factor, L-S-nitrosocysteine, in conscious Spontaneously Hypertensive rats.
Lewis SJ; Hashmi-Hill MP; Owen JR; Sandock K; Robertson TP; Bates JN
Vascul Pharmacol; 2006 Jun; 44(6):491-507. PubMed ID: 16713366
[TBL] [Abstract][Full Text] [Related]
12. S-nitrosocaptopril interrupts adhesion of cancer cells to vascular endothelium by suppressing cell adhesion molecules via inhibition of the NF-кB and JAK/STAT signal pathways in endothelial cells.
Lian S; Lu Y; Cheng Y; Yu T; Xie X; Liang H; Ye Y; Jia L
Eur J Pharmacol; 2016 Nov; 791():62-71. PubMed ID: 27565222
[TBL] [Abstract][Full Text] [Related]
13. S-nitrosocaptopril: acute in-vivo pulmonary vasodepressor effects in pulmonary hypertensive rats.
Tsui DY; Gambino A; Wanstall JC
J Pharm Pharmacol; 2003 Aug; 55(8):1121-5. PubMed ID: 12956902
[TBL] [Abstract][Full Text] [Related]
14. S-nitrosocaptopril. I. Molecular characterization and effects on the vasculature and on platelets.
Loscalzo J; Smick D; Andon N; Cooke J
J Pharmacol Exp Ther; 1989 Jun; 249(3):726-9. PubMed ID: 2659776
[TBL] [Abstract][Full Text] [Related]
15. Effects of a novel ACE inhibitor, 3-(3-thienyl)-l-alanyl-ornithyl-proline, on endothelial vasodilation and hepatotoxicity in l-NAME-induced hypertensive rats.
Seth MK; Hussain ME; Pasha S; Fahim M
Drug Des Devel Ther; 2016; 10():1533-42. PubMed ID: 27143859
[TBL] [Abstract][Full Text] [Related]
16. Nitric oxide inhibits hetero-adhesion of cancer cells to endothelial cells: restraining circulating tumor cells from initiating metastatic cascade.
Lu Y; Yu T; Liang H; Wang J; Xie J; Shao J; Gao Y; Yu S; Chen S; Wang L; Jia L
Sci Rep; 2014 Mar; 4():4344. PubMed ID: 24614329
[TBL] [Abstract][Full Text] [Related]
17. S-nitrosocaptopril formation in aqueous acid and basic medium. A vasodilator and angiotensin converting enzyme inhibitor.
Sexto A; Iglesias E
Org Biomol Chem; 2011 Oct; 9(20):7207-16. PubMed ID: 21860877
[TBL] [Abstract][Full Text] [Related]
18. Captopril and S-nitrosocaptopril as potent radiosensitizers: Comparative study and underlying mechanisms.
Jordan BF; Peeterbroeck J; Karroum O; Diepart C; Magat J; Grégoire V; Gallez B
Cancer Lett; 2010 Jul; 293(2):213-9. PubMed ID: 20144849
[TBL] [Abstract][Full Text] [Related]
19. The effects of S-nitrosocaptopril on canine coronary circulation.
Nakae I; Takahashi M; Kinoshita T; Matsumoto T; Kinoshita M
J Pharmacol Exp Ther; 1995 Jul; 274(1):40-6. PubMed ID: 7616425
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary hypertension, nitric oxide and nitric oxide-releasing compounds.
Hagan G; Pepke-Zaba J
Expert Rev Respir Med; 2011 Apr; 5(2):163-71. PubMed ID: 21510727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
